The supramolecular synthon approach uses crystal engineering (7) to carefully analyze the relevant supramolecular arrangements that an API might exhibit by utilizing the Cambridge Structural Database (CSD) (8) and effectively prioritizes all possible guest molecules for crystal form screening of drugs